Celltrion Announces Agreement With Brazilian Government To Supply Infliximab Biosimilar
05 April 2022
Goodwin Procter LLP
To print this article, all you need is to be registered or login on Mondaq.com.
On March 24, 2022, Celltrion Healthcare announced that it had won a bid to the
Brazilian Federal Government to supply a biosimilar version of
Remsima® (infliximab), along with bids to 12 Brazilian
states. According to the company, infliximab will be the
third biosmilar product that Celltrion is to supply to the
Brazilian market after Celltrion reached agreement in 2021 with the
Brazilian Ministry of Health to supply Truxima®
(Celltrion's rituximab biosimilar) and Herzuma®
(Celltrion's trastuzumab biosimilar).
Dr. HoUng Kim, Ph.D., Head of Medical and Marketing Division at
Celltrion Healthcare said that as a result of sales to the
Brazilian government and the private sector, Celltrion expects
"to achieve approximately two-thirds of the total Brazilian
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from Brazil
New Definition Of Strategic Medicines
The Regulation STFP-009-725-2023 of March 15, 2023 (the "Regulation"), issued by the Board for Fixing and Reviewing the Prices of Medicines for Human Use and Consumption (the "Board")...
New Regulation For The Use Of Probiotics In Chile
Recently, the Public Health Institute ("ISP" for its acronym in Spanish) issued Resolution No. 3435, according to which it establishes the control regime applicable to, "products in pharmaceutical oral forms...
New Post-Approval Changes Of Drug Products
Moeller IP Advisors
On March 22, 2016, the Brazilian Health Authority (ANVISA) approved the amendments of Regulation RDC 48/2009, which refers to the post-approval changes of drug products.
Registration Of Food Products Now Online Only
Moeller IP Advisors
Beginning April 7, 2016, the registration of food products before the INAL, a division of the ANMAT, can only be made electronically through the Federal Information System for Food Control Management.
Mexican Official Standard NOM-142-SSA1/SCFI-2014, Alcoholic Beverages, Health Specifications And Commercial Labeling
Basham, Ringe y Correa, S.C.
On March 23, 2015, the Mexican Official Standard NOM-142-SSA1/SCFI-2014, alcoholic beverages, health specifications, and commercial labeling, was published in the Federal Official Gazette...